作者
Marc J Claeys, Adel Aminian, Jozef Bartunek, Johan Bennett, Ian Buysschaert, Mathias Claeys, Dina De Bock, Lies Delodder, Philippe Debonnaire, Willem Dewilde, Bert Ferdinande, Stéphanie Geerinck, Kaatje Goetschalckx, Olivier Lambrechts, Stijn Lochy, Bernard P Paelinck, Liesbeth Rosseel, Didier Stroobants, Marc Vanderheyden, Jan Van der Heyden, Peter Verbrugghe, Stefan Verheye, Christophe Dubois
发表日期
2024/2
期刊
Catheterization and Cardiovascular Interventions
卷号
103
期号
2
页码范围
382-388
简介
Background
Evidence‐based recommendations for antithrombotic treatment in patients who have an indication for oral anticoagulation (OAC) after transcatheter edge‐to‐edge mitral valve repair (TEER) are lacking.
Aims
To compare bleeding and thrombotic risk for different antithrombotic regimens post‐TEER with MitraClip in an unselected population with the need for OACs.
Methods
Bleeding and thrombotic complications (stroke and myocardial infarction) up to 3 months after TEER with mitraclip were evaluated in 322 consecutive pts with an indication for OACs. These endpoints were defined by the Mitral Valve Academic Research Consortium criteria and were compared between two antithrombotic regimens: single antithrombotic therapy with OAC (single ATT) and double/triple ATT with a combination of OAC and aspirin and/or clopidogrel (combined ATT).
Results
Collectively, 108 (34%) patients received …
学术搜索中的文章
MJ Claeys, A Aminian, J Bartunek, J Bennett… - Catheterization and Cardiovascular Interventions, 2024